The company appealed against rejection of its challenge to the licensing and classification system applied to its products.
Longmore, Lewison, McCombe LJJ
[2016] EWCA Civ 554
Bailii
Directive 2001/83/EC
England and Wales
Citing:
Appeal from – Blue Bio Pharmaceuticals Ltd and Another, Regina (on The Application of) v Secretary of State for Health (Mhra) Admn 22-May-2014
The Claimants complained that the Defendant wrongly refused to treat as medicinal products the large number of GCPs (glucosamine-containing product) described as ‘food supplements’.
Held: The claim failed. . .
Lists of cited by and citing cases may be incomplete.
Health Professions, European
Updated: 17 January 2022; Ref: scu.565724